Response to vinorelbine and low-dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor

Research output: Contribution to journalArticlepeer-review

Abstract

We report two cases of abdominal desmoplastic small round cell tumor (DSRCT) that showed a clinical response to the vinorelbine/low-dose cyclophosphamide combination that has been claimed to be effective for rhabdomyosarcoma. This observation may prompt further investigation into the activity of such a regimen in DSRCT patients with recurrent or refractory disease, with a view to a possible future role as maintenance therapy in controlling minimal residual disease in patients who achieve complete remission with intensive induction multimodality therapy.

Original languageEnglish
Pages (from-to)864-866
Number of pages3
JournalPediatric Blood and Cancer
Volume49
Issue number6
DOIs
Publication statusPublished - Nov 2007

Keywords

  • Desmoplastic small round cell tumor
  • Low-dose cyclophosphamide
  • Metronomic therapy
  • Vinorelbine

ASJC Scopus subject areas

  • Cancer Research
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Fingerprint Dive into the research topics of 'Response to vinorelbine and low-dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor'. Together they form a unique fingerprint.

Cite this